Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial
The European Organisation for Research and Treatment of Cancer and Immunocore (IMCR) Holdings announced the randomization of the first patient ...
Taiwan News9 小时
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 ...
ATOM is the only active Phase 3 trial for adjuvant treatment of uveal melanoma The trial will assess whether adjuvant treatment with tebentafusp can decrease the risk of relapse, compared to ...
News Medical18 小时
Key plasma proteins signal critical periods in brain aging
Researchers identified 13 plasma proteins linked to brain aging, uncovering dynamic patterns and biomarkers for early ...